Proven.Proactive.Growth partner.
Capital investment for next-stage growth, backed by leading entrepreneurs and former founders with a proven track record of commercial success.
Built by operators. For founder-led businesses.
Growth Fund 1 is fully focused on delivery for its portfolio and investors, in a dedicated one-fund model.
- Proven founders, backed by a self-invested advisory panel
- Networks and judgement to guide growth and exit
- UK-based, founder-led businesses
- B2B markets across professional services, human capital, healthcare and agency models
- Founder-led businesses at key inflection points
- 2–4 year hold, hands-on with management
- Largely off-market opportunities
- Investors are hands-on operators
- Practical experience, strategic input, full alignment

Active involvement in every growth project.
Experience is our USP.
Backed by leading entrepreneurs and a panel of experienced, self-invested advisory members.
- Founder, CEO and Co-Chairman of Marlin Green, pan-European tech recruitment
- Built over 11 years: 17+ countries, offices in London and Düsseldorf
- Exited 2021 in an Inflexion-backed trade deal; earn-outs and loan notes fully redeemed
- Retained as NED and Steering Committee member
A proven operational team of capable, responsive and highly experienced professionals.
- Durham University & BPP Law School
- Leads deal origination
- Private equity background; scale-up focus
- 30+ years in senior finance, including private equity
- Leads financial due diligence
- Oversees financial best practice to exit
- 20+ years in operational growth and tech enablement
- Supported businesses from start-up to £30M+ exits
- Advises on tech integration and efficiency
Where we’re invested.
- Award-winning UK commercial charge point operator
- End-to-end for business, landowners and public sector
- No-upfront-cost funding; nationwide coverage
- Pharmacist-led training and consultancy for primary care
- Nearly 20 years; 16,000+ member network
- CPD, specialist academies, medication reviews
- Clinical pharmacy and medicines management for the NHS
- Tailored plans for efficiency, quality and patient safety
- Scalable delivery across GP practices
In the press.
We know how to
land a target.
Growth Capital 1 LTD (FRN 1001418) is an appointed representative of Panima Capital Management Limited (FRN 653812), which is authorised and regulated by the Financial Conduct Authority. Member, UK Private Capital. All rights reserved.


